PCM
RENE

Prelude Capital Management’s Cartesian Growth Corp II RENE Stock Holding History

Prelude Capital Management’s Portfolio RENE Stock Details RENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-244,500
Closed -$2.51M – 1420
2022
Q4 		$2.51M Hold
244,500
– – 0.13% 180
2022
Q3 		$2.46M Buy
+244,500
New +$2.45M 0.09% 181

Other funds holding RENE

CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $28.2B AUM 21.78% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Prelude Capital Management's RENE Position: Q1 2023 in Review

Prelude Capital Management sold out of Cartesian Growth Corp II (RENE) in Q1 2023, closing a stake of 244,500 shares — an estimated $2.51M sold.

Prelude Capital Management first reported a position in RENE in Q3 2022 and held it in 2 quarters. The position peaked at $2.51M in Q4 2022. 50 funds tracked by Wall St. Rank hold RENE as of Q1 2023.

  • Prelude Capital Management reported no remaining Cartesian Growth Corp II position as of Q1 2023 after selling out during the quarter.
  • Prelude Capital Management sold 244,500 Cartesian Growth Corp II shares in Q1 2023, an estimated $2.51M.
  • Prelude Capital Management first reported a position in Cartesian Growth Corp II in Q3 2022 and held it in 2 quarters.
  • Prelude Capital Management's Cartesian Growth Corp II position peaked at $2.51M in Q4 2022.
  • 50 funds tracked by Wall St. Rank held Cartesian Growth Corp II as of Q1 2023.

Based on Prelude Capital Management's 13F filing for Q1 2023, filed 15 May 2023.